PT  - JOURNAL ARTICLE
AU  - Samuel B. Snider
AU  - Nancy R. Temkin
AU  - Jason Barber
AU  - Brian L. Edlow
AU  - Joseph T. Giacino
AU  - Flora M. Hammond
AU  - Saef Izzy
AU  - Robert G. Kowalski
AU  - Amy J. Markowitz
AU  - Craig A. Rovito
AU  - Shirley L. Shih
AU  - Ross D. Zafonte
AU  - Geoffrey T. Manley
AU  - Yelena G. Bodien
AU  - The TRACK-TBI Investigators
TI  - Predicting Functional Dependency in Patients with Disorders of Consciousness: A TBI-Model Systems and TRACK-TBI Study
AID  - 10.1101/2023.03.14.23287249
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.14.23287249
4099  - http://medrxiv.org/content/early/2023/03/15/2023.03.14.23287249.short
4100  - http://medrxiv.org/content/early/2023/03/15/2023.03.14.23287249.full
AB  - Importance There are currently no models that predict long-term functional dependency in patients with disorders of consciousness (DoC) after traumatic brain injury (TBI).Objective Fit, test, and externally validate a prediction model for 1-year dependency in patients with DoC 2 or more weeks after TBI.Design Secondary analysis of patients enrolled in TBI Model Systems (TBI-MS, 1988-2020, Discovery Sample) or Transforming Research and Clinical Knowledge in TBI (TRACK-TBI, 2013-2018, Validation Sample) and followed 1-year post-injury.Setting Multi-center study at USA rehabilitation hospitals (TBI-MS) and acute care hospitals (TRACK-TBI).Participants Adults with TBI who were not following commands at rehabilitation admission (TBI-MS; days post-injury vary) or 2-weeks post-injury (TRACK-TBI).Exposures In the TBI-MS database (model fitting and testing), we screened demographic, radiological, clinical variables, and Disability Rating Scale (DRS) item scores for association with the primary outcome.Main Outcome The primary outcome was death or complete functional dependency at 1-year post-injury, defined using a DRS-based binary measure (DRSDepend), indicating need for assistance with all activities and concomitant cognitive impairment.Results In the TBI-MS Discovery Sample, 1,960 subjects (mean age 40 [18] years, 76% male, 68% white) met inclusion criteria and 406 (27%) were dependent at 1-year post-injury. A dependency prediction model had an area under the receiver operating characteristic curve (AUROC) of 0.79 [0.74, 0.85], positive predictive value of 53%, and negative predictive value of 86% for dependency in a held-out TBI-MS Testing cohort. Within the TRACK-TBI external validation sample (N=124, age 40 [16], 77% male, 81% white), a model modified to remove variables not collected in TRACK-TBI, had an AUROC of 0.66 [0.53, 0.79], equivalent to the gold-standard IMPACTcore+CT score (0.68; 95% AUROC difference CI: -0.2 to 0.2, p=0.8).Conclusions and Relevance We used the largest existing cohort of patients with DoC after TBI to develop, test and externally validate a prediction model of 1-year dependency. The model’s sensitivity and negative predictive value were greater than specificity and positive predictive value. Accuracy was diminished in an external sample, but equivalent to the best-available models. Further research is needed to improve dependency prediction in patients with DoC after TBI.Competing Interest StatementDr. Snider is a site investigator on a Biogen-funded clinical trial unrelated to this work. Dr. Izzy receives funding from National Institute of Health and royalties from McGraw-Hill Education Publishing Dr. Hammond receives royalties from Springer/Demos and Lash Publishing. Dr. Zafonte reported receiving royalties from Springer/Demos for the text Brain Injury Medicine as well as serving on the scientific advisory boards of Myomo, and One Care.ai. Dr. Giacino reported receiving a grant from the National Football League outside the submitted work. Ms. Markowitz reports a contract with the US Department of Defense (contract W81XWH-15-9-0001), and personal fees from One Mind during the conduct of the study. Dr. Manley received funding for TRACK-TBI patient stipends and support to clinical sites from One Mind; and support for TRACK-TBI data curation efforts from Neurotrauma Sciences LLC during the conduct of the study. All other authors report no relevant disclosures. Funding StatementDr. Snider receives funding from the American Academy of Neurology (Clinical Research Training Scholarship). Dr. Temkin receives funding from NIH National Institute of Neurological Disorders and Stroke and Department of Defense. Dr. Edlow receives funding from the NIH National Institute of Neurological Disorders and Stroke (R21NS109627 RF1NS115268) NIH Directors Office (DP2HD101400) and James S. McDonnell Foundation. Dr. Giacino receives funding from National Institutes of Health National Institute of Neurologic Disorders and Stroke (U01 NS1365885) and U.S. Department of Defense (# W81XWH-14-2-0176 MTEC-18-03-DTTBI-0001). Dr. Hammond receives funding from National Institute on Disability Independent Living, and Rehabilitation Research (grants 90DPTB0022 90DPTB0002 90DPHF0006 90DPTB0017 and 90RTEM0008); National Institutes of Health (UG3NS117844 and 1R01NS118009) PCORI UWSC9923/PCS-1604-35115; Department of Defense (W81XWH-18-1-0796); University of California- San Francisco; University of Michigan (SUBK10416CSPR-002). Dr. Izzy receives funding from the NIH National Institute of Neurological Disorders and Stroke (1K08NS123503). Dr. Kowalski receives funding from: NIH National Institute of Neurological Disorders and Stroke (LRP). Dr. Zafonte receives funding from National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) Administration for Community Living (90DPCP0008-01-00 90DP0039) Dr. Manley reported receiving grants from the US Department of Defense TBI Endpoints Development Initiative US Department of Defense TRACK-TBI Precision Medicine and NIH-NINDS TRACK-TBI; research support from the US Department of Defense/MTEC TRACK-TBI NETWORK; support from the US Department of Energy for a precision medicine collaboration. Ms. Markowitz receives funding from the US Department of Defense (grant W81XWH-14-2-0176). Dr. Bodien receives funding from: NIH National Institute of Neurological Disorders and Stroke (U01 NS136588 U01-NS086090) and the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) Administration for Community Living (90DPCP0008-01-00 90DP0039). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mass General Brigham Institutional Review Board provides local oversight and gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors